66.2134  -0.462 (-0.69%)		10-16 16:00
Open: 68.225 High: 69.01 Volume: 25,557		Pre. Close: 66.6758 Low: 65.566 Market Cap: 59(M)

Short term
Mid term
Targets	6-month :	80.6	1-year :	94.14
Resists	First :	69.01	Second :	80.6
Pivot price	63.38
Supports	First :	60.56	Second :	55.34
MAs	MA(5) :	65.15	MA(20) :	61.92
	MA(100) :	53.18	MA(250) :	52.73
MACD	MACD :	2.3	Signal :	2.1
%K %D	K(14,3) :	86.7	D(3) :	84.9
RSI	RSI(14): 67.8
52-week	High :	69.01	Low :	33.77

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BIB ] has closed below upper band by 24.4%. Bollinger Bands are 75.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	69.05 - 69.4	69.4 - 69.67
Low:	64.77 - 65.13	65.13 - 65.4
Close:	65.64 - 66.25	66.25 - 66.71

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Tue, 07 Oct 2025
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network

Thu, 22 Feb 2024
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 - InvestorPlace

Fri, 14 Apr 2023
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering and Biotechnology News

Wed, 22 Dec 2021
Top Biotechnology Indexes in the U.S. and How to Invest in Them - Nasdaq

Mon, 13 Dec 2021
atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index - Psychedelic Alpha

Tue, 20 Jul 2021
Biotech Industry Working to Keep Up with Covid Mutations - ETF Database

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.